A new drug to treat HIV just got approved - and it could shake up a $22 billion market


The pill, which contains dolutegravir with rilpivirine, is made by ViiV, the specialist HIV company majority owned by GlaxoSmithKline, that has Pfizer and Japanese pharmaceutical company Shionogi as shareholders. Up until now, people living with HIV suppress the virus with a regimen of three or four pills.



from Biotech News